What percentage of the drug was most likely lipid soluble in the patient's duodenal lumen?
Rationale:
The drug was most likely 24% lipid soluble in the patient's duodenal lumen. This percentage aligns with typical solubility profiles where partial lipid solubility facilitates absorption through the duodenal membrane without complete hydrophobicity, balancing bioavailability and transport efficiency. It reflects moderate partitioning into lipid environments, crucial for effective drug uptake in the duodenum’s lipid-rich milieu.
A: 1% reflects minimal lipid affinity, insufficient for meaningful membrane permeation or absorption in the lipid-rich duodenal environment.
C: 50% overestimates lipid solubility, likely causing excessive drug retention in lipid phases, reducing bioavailability and transport efficiency.
D: 76% suggests predominant lipid solubility, which could impair aqueous phase transport and limit systemic absorption, inconsistent with observed data.
The nurse is reviewing the drug-approval process in the United States and learns that the Food and Drug Administration Modernization Act of 1997 contains which provisions? (Select all that apply.)
Rationale:
The Food and Drug Administration Modernization Act of 1997 includes provisions to accelerate the review of new drugs. This act was designed to speed up the availability of important medications by streamlining the approval process, thereby allowing patients quicker access to innovative treatments while maintaining safety and efficacy standards set by the FDA.
B: Drug companies are not required by this act to provide information on off-label drug use; it primarily focuses on the approval process rather than marketing or prescribing practices.
C: Privacy of individually identifiable health information is governed by HIPAA regulations, not the FDA Modernization Act, which centers on drug approval and regulation.
D: The act does not mandate drug companies to offer advanced notice of discontinuing drugs; its emphasis lies on expediting drug review and approval procedures.
When developing an individualized medication teaching plan, which topics will the nurse include? (Select all that apply.)
Rationale:
Adherence to the prescribed drug regimen is included in the individualized medication teaching plan. This topic ensures patients understand the importance of following dosage instructions precisely to achieve therapeutic effects and avoid complications. Proper adherence minimizes risks of underdosing, overdosing, or resistance, promoting safety and efficacy in treatment. It is fundamental for optimal health outcomes in medication management.
B: Always use the prescribed drug route instructs patients on correct administration pathways, but it is a specific directive rather than a broad teaching topic focused on understanding medication impact and overall regimen adherence.
C: Know adverse side effects to report to doctor enhances patient safety awareness but is a subset of medication knowledge rather than a comprehensive behavioral focus like adherence, which addresses the entire regimen's execution.
D: Always double the next dose if drug is missed promotes unsafe practices and contradicts standard guidelines, risking overdose and adverse reactions, thus it is never included in patient teaching plans.
Important factor/s which may govern diffusion of drugs across cell membranes
Rationale:
Diffusion of drugs across cell membranes is governed by all of the above factors. The pKa value affects the ionization state, pH of the medium influences drug ionization, and lipid solubility determines the ability to traverse the lipid bilayer. Together, these factors collectively impact the drug’s permeability and absorption efficiency across biological membranes.
A: pKa value of the drug influences ionization but does not alone determine diffusion since pH and lipid solubility also significantly affect membrane passage.
B: pH of the medium affects ionization state but without considering pKa and lipid solubility, it cannot fully explain the diffusion process.
C: Lipid solubility governs membrane permeability but is insufficient alone as ionization state influenced by pKa and pH also plays a critical role.
Which of the following is most likely the main site of distribution of infliximab?
Rationale:
Infliximab is most likely to primarily distribute into fat tissue.
Infliximab, a monoclonal antibody, is a large molecule that tends to localize within fat tissue due to its hydrophobic interactions and limited ability to penetrate intracellular spaces. Its distribution is predominantly extracellular, with fat tissue providing a significant reservoir, unlike smaller molecules that freely circulate in plasma or intracellular compartments.
B: Plasma Monoclonal antibodies like infliximab are large molecules that do not primarily remain in plasma but distribute more extensively into tissues, especially fat, limiting their confinement to plasma.
C: Extracellular fluids Although infliximab distributes extracellularly, extracellular fluids are a broad category and less specific than fat tissue, which serves as a concentrated main distribution site due to molecular affinity.
D: Cell cytosol Cell cytosol is intracellular and generally inaccessible to large antibody molecules like infliximab, which cannot effectively cross cell membranes to accumulate inside cells.
A 52-year-old woman with multiple endocrine neoplasia syndromes has a large pancreatic tumor and bilateral adrenal tumors. She is hospitalized on the medicine service. The tumor is considered inoperable. Her blood pressure is $180 / 100 \mathrm{~mm} \mathrm{Hg}$. In addition to intravenous fluids, this patient may benefit from which of the following interventions?
Rationale:
Phentolamine, intravenous route is beneficial in this patient for rapid blood pressure control due to its alpha-adrenergic blockade, particularly in pheochromocytoma crises. This patient’s hypertensive emergency from adrenal tumors requires fast-acting, reversible alpha blockade to prevent catecholamine-induced vasoconstriction and hypertensive complications. Intravenous phentolamine provides immediate, effective management in critical settings.
A: Analgesics, oral route provide pain relief but do not address the acute hypertensive crisis caused by catecholamine excess in pheochromocytoma. Oral administration is slower and insufficient for emergency blood pressure control.
B: Analgesics, transdermal route cannot rapidly reduce severe hypertension or catecholamine effects; transdermal absorption is too slow and ineffective in managing life-threatening hypertensive emergencies in pheochromocytoma.
C: Phenoxybenzamine, intravenous route is unavailable; phenoxybenzamine is given orally and acts slowly, making it unsuitable for immediate blood pressure control in acute pheochromocytoma crises requiring rapid intervention.
The colligative properties of a solution are related to the
Rationale:
The colligative properties of a solution are related to the total number of solute particles in the solution. These properties depend on solute particle quantity, not their identity or charge, affecting vapor pressure, boiling point, freezing point, and osmotic pressure. The total particle concentration influences these effects, regardless of whether solutes ionize or remain as molecules, emphasizing particle count's central role in colligative behavior.
A: pH of the solution focuses on hydrogen ion concentration, which influences acidity or alkalinity, but does not determine colligative properties directly linked to particle quantity.
B: Number of ions in the solution refers only to charged particles, excluding non-ionized solutes, thus not fully representing total particle effects on colligative properties.
D: Number of unionized molecules in the solution ignores ionized solutes, missing the entire spectrum of particles that influence colligative properties through their total count.
The oral bioavailability of a drug:
Rationale:
The oral bioavailability of a drug is a measure of the extent to which it enters the systemic circulation. This definition captures the fundamental concept of bioavailability, focusing on the proportion of the administered dose that reaches systemic circulation intact, reflecting absorption and first-pass metabolism. It quantifies how much of the drug is actually available to exert its therapeutic effect after oral administration.
B: May be influenced by changing the excipient after oral administration highlights formulation factors but does not define bioavailability itself. Excipients affect drug release, not the intrinsic measure of systemic entry.
C: Is defined as the ratio of the area under the plasma concentration time curve (AUC) following oral administration divided by that following intravenous administration describes absolute bioavailability, not the general concept of oral bioavailability alone.
D: May be reduced by hepatic CYP450 induction focuses on metabolic factors that alter bioavailability but does not define what oral bioavailability measures, which is systemic entry extent.
The foundation of clinical trials, Good Clinical Practice, is a helpful resource for nurses. The nurse is correct in choosing Good Clinical Practice as a reference for standards in which areas? (Select all that apply.)
Rationale:
Good Clinical Practice serves as a reference for standards in the design of clinical trials. It provides comprehensive guidelines ensuring trials are ethically sound, scientifically valid, and protect participant rights, focusing primarily on the planning and structuring phase. This foundational framework aids nurses in understanding how trials should be properly constructed for reliability and compliance.
B: Monitoring and auditing pertain more to trial oversight and quality assurance processes, which are detailed in other regulatory documents rather than the initial design guidelines of Good Clinical Practice.
C: Analyses involve data evaluation and statistical methods, areas typically governed by specialized protocols beyond the scope of Good Clinical Practice’s core design standards.
D: Reporting focuses on the dissemination of trial results and transparency, which, while important, is not the primary concern addressed in the Good Clinical Practice design principles.
In vomiting with pregnancy, it is safe to use:
Rationale:
Vomiting with pregnancy is safely treated using Meclezine + Pyridoxine.
Meclezine combined with Pyridoxine is preferred because it effectively manages nausea and vomiting without posing significant risks to the fetus. Pyridoxine (vitamin B6) is well-recognized for its safety profile in pregnancy, while Meclezine reduces motion sickness symptoms. This combination balances therapeutic benefits and fetal safety, making it the recommended option.
A: Hyoscine is avoided because its anticholinergic effects could cause adverse maternal or fetal outcomes, lacking sufficient safety data during pregnancy.
C: Ondansetron’s safety in pregnancy is debated due to limited conclusive evidence, with some studies suggesting potential teratogenic risks, so it’s not the first choice.
D: Diazepam has sedative and teratogenic potential, posing risks such as fetal malformations and neonatal withdrawal, rendering it unsuitable for treating pregnancy-related vomiting.
Filgrastim (human granulocyte colony-stimulating factor):
Rationale:
Filgrastim stimulates proliferation and differentiation of myeloid progenitor cells. It acts as a granulocyte colony-stimulating factor (G-CSF), promoting the growth and maturation of neutrophil precursors in the bone marrow, thereby enhancing neutrophil production and function, which is essential in treating neutropenia and supporting immune recovery in patients undergoing chemotherapy or bone marrow transplantation.
A: Is usually administered by subcutaneous injection This is true for filgrastim but does not describe its mechanism or primary action, which is the stimulation of myeloid progenitor cell growth.
B: Causes immediate transient neutropenia Filgrastim actually increases neutrophil counts rather than causing neutropenia, making this statement inconsistent with its pharmacological effects.
C: Is used in myeloid leukaemia Filgrastim is not indicated for myeloid leukemia treatment; it primarily supports neutrophil recovery, not leukemia therapy or management.
Which site of drug absorption is considered to have the largest surface area?
Rationale:
The lungs have the largest surface area for drug absorption. The extensive alveolar surface, thin epithelial barrier, and rich capillary network create an optimal environment for rapid and efficient drug absorption into systemic circulation, surpassing other sites in both area and permeability. This makes the lungs uniquely suited for inhaled drug delivery.
A: Rectum offers limited surface area compared to the lungs, with less extensive vascularization and mucosal folds, reducing overall drug absorption efficiency despite its venous drainage advantages.
B: Vagina’s surface area is comparatively small, with a mucosal lining not specialized for large-scale absorption, limiting its capacity for efficient systemic drug uptake.
C: The eye has a minimal absorptive area focused mainly on protection and vision, lacking the expansive vascularized surface necessary for significant systemic drug absorption.
The following infections have been paired with appropriate antibacterial therapy:
Rationale:
Acute otitis media is appropriately treated with amoxicillin. Amoxicillin is the first-line antibiotic due to its effectiveness against common pathogens like Streptococcus pneumoniae and Haemophilus influenzae. It penetrates middle ear fluid well and has a favorable safety profile in children, making it the standard initial therapy for uncomplicated acute otitis media cases.
B: Acute epiglottitis requires third-generation cephalosporins like cefotaxime or ceftriaxone, but chloramphenicol is less favored due to toxicity and resistance concerns, making this pairing partially inaccurate.
C: Legionnaire's disease treatment typically involves macrolides or fluoroquinolones; combining erythromycin with rifampicin is not standard and rifampicin is rarely used due to resistance risks.
D: Acute cystitis outside hospital settings is commonly treated with nitrofurantoin or fosfomycin; trimethoprim use is limited by increasing resistance and is not universally appropriate.
Cross MATCH each drug to its specific adverse effect: Paraffin oil
Rationale:
Paraffin oil is specifically associated with lipid pneumonia as its adverse effect. This occurs due to aspiration of the oil into the lungs, leading to an inflammatory reaction and lipid accumulation in pulmonary tissues. Unlike other drugs, paraffin oil’s oily nature predisposes it to causing this rare but serious pulmonary complication rather than gastrointestinal or systemic metabolic effects.
A: Intestinal obstruction if not taken with plenty of fluids does not align with paraffin oil, which acts as a lubricant laxative rather than causing blockages.
B: Mutagenic effects are unrelated to paraffin oil, which lacks carcinogenic or genetic toxicity properties seen with certain chemotherapeutic agents.
D: Flatulence and aggravation of diabetes are not associated with paraffin oil, which primarily affects lipid metabolism locally, not systemic glucose or gas production.
Which of the following statements about bioavailability is true?
Rationale:
Bioavailability issues are especially important for drugs with narrow therapeutic ranges or sustained release mechanisms. This is because slight variations in absorption can lead to subtherapeutic effects or toxicity in drugs with narrow margins. Sustained release formulations rely on controlled absorption rates, making bioavailability critical to maintaining consistent therapeutic levels and patient safety over time.
B: All brands of a drug have the same bioavailability is inaccurate since different manufacturers may use distinct formulations, excipients, or manufacturing processes, causing variability in drug absorption and therapeutic effectiveness.
C: Drugs that are administered more than once a day have greater bioavailability than drugs given once daily is misleading; dosing frequency does not inherently improve absorption or the fraction of drug reaching systemic circulation.
D: Combining an active drug with an inert substance does not affect bioavailability is false because excipients or inert substances can influence dissolution, absorption rates, or stability, thereby altering the drug’s bioavailability.
A nurse caring for a child with developmental delay prepares to teach the patient about prescribed drugs. Which actions are essential to ensure patient safety? (Select all that apply.)
Rationale:
Assess the child’s developmental age.
Assessing the child’s developmental age is crucial because drug effects and safety often depend on developmental status rather than chronological age. This approach ensures the nurse tailors education and monitoring appropriately, considering cognitive, physical, and emotional maturity, which influences drug metabolism, understanding, and adherence. It promotes effective communication and safer medication management in children with developmental delays.
B: Assess for side effects the same as those experienced by adults. This option overlooks pediatric pharmacodynamics variations; children may experience different or additional side effects needing specific observation protocols distinct from adults.
C: Consider the actions and uses of the drug. While important, this alone is insufficient without evaluating the child’s developmental context, which directly affects drug response and safety in pediatric patients.
D: Focus on the child’s chronologic age. Chronological age does not reliably reflect developmental maturity or drug metabolism in children with delays, risking inappropriate dosing or misunderstanding of drug effects.
Monitoring plasma/serum drug concentrations of the following drugs is recognized as a valuable supplement to clinical monitoring:
Rationale:
Monitoring plasma/serum drug concentrations of gentamicin is recognized as a valuable supplement to clinical monitoring. Gentamicin has a narrow therapeutic index and variable pharmacokinetics, making serum level measurements essential to avoid toxicity and ensure efficacy. Therapeutic drug monitoring helps adjust doses, prevent nephrotoxicity and ototoxicity, and optimize treatment outcomes, especially in patients with renal impairment or fluctuating clearance.
A: Carbimazole Serum drug level monitoring is not routine for carbimazole due to its mechanism acting on thyroid synthesis, where clinical and thyroid function tests suffice for therapeutic assessment.
B: Warfarin Monitoring relies primarily on INR values reflecting anticoagulant effect rather than direct plasma concentration, making drug level measurement unnecessary and not clinically informative.
D: Lithium Regular serum lithium levels are essential, but the question specifies valuable supplements; lithium monitoring is standard clinical practice, not merely supplementary, differing from gentamicin’s supplemental role in monitoring.
Drugs with small volume of distribution (Vd) are characterized by
Rationale:
Drugs with small volume of distribution (Vd) are characterized by all of the above.
Small Vd drugs primarily remain within the plasma and extracellular fluid, indicating limited tissue uptake. Their confinement to vascular compartments allows effective removal via dialysis during toxicity. Additionally, the Vd for these drugs typically does not fall below approximately 5 liters, reflecting the plasma volume's approximate capacity.
A: Limited tissue uptake alone does not cover dialysis utility or Vd thresholds, missing complete characterization.
B: Dialysis usefulness in toxicity is only part of the profile, ignoring tissue distribution and volume limits.
C: Vd cannot be less than 5 liters is an inaccurate absolute, neglecting other defining pharmacokinetic features.
Agents that may be used to coat enteric coated tablets include
Rationale:
Cellulose acetate phthalate is an agent used to coat enteric coated tablets. This polymer resists gastric acid, preventing tablet dissolution in the stomach, and enables targeted drug release in the intestine. Its acid-insoluble yet intestinal-soluble properties make it ideal for enteric coatings, protecting active ingredients from stomach acid and ensuring proper therapeutic effect.
A: Hydroxypropyl methyl cellulose functions primarily as a film-forming agent and binder but lacks acid-resistant properties necessary for enteric protection, thus unsuitable for enteric coatings.
B: Carboxymethyl cellulose serves mostly as a thickener or stabilizer, not providing the acid resistance required to prevent tablet dissolution in the stomach environment.
D: None listed disregards that cellulose acetate phthalate is a well-established enteric coating polymer widely used in pharmaceutical formulations.
The following concerning venlafaxine is not true:
Rationale:
Anticholinergic side effects are not frequently encountered with venlafaxine use. Venlafaxine primarily inhibits serotonin and norepinephrine reuptake without significant anticholinergic activity, making side effects like dry mouth or blurred vision uncommon. Its side effect profile is dominated by nausea and potential hypertension, rather than typical anticholinergic symptoms, distinguishing it from tricyclic antidepressants that exhibit these effects more often.
B: It is a norepinephrine serotonin reuptake inhibitor. This accurately describes venlafaxine’s mechanism, as it blocks the reuptake of both neurotransmitters, enhancing mood regulation and justifying its classification among SNRIs.
C: Nausea is a troublesome side effect. Nausea frequently occurs with venlafaxine, often during initial treatment phases, reflecting its impact on gastrointestinal serotonin receptors.
D: Hypertension may occur during therapy. Venlafaxine can increase blood pressure due to norepinephrine effects, necessitating monitoring, especially in hypertensive patients receiving higher doses.
A patient receives a single dose of antibiotics following a prostate needle biopsy. He takes $500 \mathrm{mg}$ of ciprofloxacin immediately after completion of the procedure. The half-life of the medication is $8 \mathrm{~h}$. At approximately how many half-lives will it take for $90 \%$ of the drug to be excreted from the body?
Rationale:
It will take approximately 3.3 half-lives for 90% of ciprofloxacin to be excreted from the body.
This is because drug elimination follows first-order kinetics, where with each half-life, the drug concentration halves. After about 3.3 half-lives, roughly 10% remains, meaning 90% has been cleared, matching the pharmacokinetic principle that 3.3 half-lives correspond to 90% elimination.
A: 1 half-life leaves about 50% of the drug remaining, so only half is eliminated, far less than the 90% required for this question.
B: 2 half-lives reduce the drug to 25% remaining, meaning 75% cleared, which does not reach the 90% clearance target.
C: 3 half-lives clear approximately 87.5% of the drug, slightly under the 90% threshold, so more time is needed to reach 90%.
Codeine is an example of a(n) as the cytochrome P450 system metabolizes the drug to facilitate receptor affinity.
Rationale:
Codeine is an example of a prodrug as the cytochrome P450 system metabolizes the drug to facilitate receptor affinity. Prodrugs require metabolic activation to convert into their active forms, enhancing pharmacological effects. Codeine itself has limited activity until transformed by cytochrome P450 enzymes into morphine, which then binds effectively to opioid receptors, producing analgesic effects.
A: Agonist suggests codeine directly activates receptors without metabolic conversion, which is inaccurate since its efficacy depends on transformation into morphine.
C: Antagonist implies codeine blocks receptors, contradicting its known role of activating opioid receptors after metabolism.
D: None disregards the metabolic process essential for codeine’s activity, overlooking its prodrug status.
A 28-year-old man with seborrheic dermatitis is prescribed a topical corticosteroid crème by his dermatologist in hopes of alleviating the chronic rash and erythema on the cheeks. Which of the following steps is most critical to achieve a therapeutic drug concentration in plasma?
Rationale:
Absorption is the most critical step to achieve a therapeutic drug concentration in plasma for a topical corticosteroid. Absorption determines how much of the drug passes through the skin barrier into systemic circulation. Without adequate absorption, the drug cannot reach effective plasma levels, regardless of distribution, elimination, or metabolic modifications. Effective absorption ensures sufficient bioavailability for therapeutic action.
B: Distribution involves the dispersion of the drug throughout body compartments but does not influence the initial amount entering plasma from a topical application, making it less critical in achieving plasma concentration here.
C: Elimination refers to the removal of the drug from the body, which affects duration, not the initial plasma concentration necessary for therapeutic effects after topical administration.
D: Glycosylation is a metabolic modification not directly related to drug absorption or plasma concentration, thus irrelevant for achieving therapeutic levels of a topical corticosteroid.
The following is Wrong concerning biotransformation phase I reactions
Rationale:
D: Result in formation of non toxic polar, rapidly eliminated conjugates.
Phase I reactions primarily involve functionalization processes such as oxidation, reduction, and hydrolysis, introducing or exposing polar groups. They do not produce conjugates; instead, conjugation occurs in Phase II reactions, where drugs become more water-soluble and non-toxic for elimination. Therefore, formation of conjugates is not characteristic of Phase I biotransformation.
A: Include oxidation by CY P450 enzyme system, reduction & hydrolysis. This accurately describes Phase I reactions that involve modifying drugs to introduce or expose functional groups, setting the stage for further metabolism.
B: Unmask a polar group accurately reflects Phase I processes, which expose or add polar groups on drug molecules, increasing their hydrophilicity for subsequent conjugation or excretion.
C: Convert drug to an easily excreted ionized metabolite correctly highlights the outcome of Phase I reactions, which modify drugs into more polar, often ionized forms, facilitating renal or biliary elimination.
Abuse potential of buspirone is low because
Rationale:
Buspirone’s abuse potential is low because it has a delayed onset of action. This slower therapeutic effect reduces immediate reinforcement, diminishing the likelihood of misuse or dependence. Unlike fast-acting drugs, buspirone’s gradual symptom relief does not produce rapid euphoria or reward pathways activation, which are key factors in substances with higher addiction risks, thus lowering its abuse liability.
A: It has a weak anxiolytic effect. The anxiolytic strength does not directly correlate with abuse potential; some potent anxiolytics still carry high abuse risks, so this reasoning does not sufficiently explain buspirone’s low abuse profile.
B: It has no recognizable effect on brain neurotransmitters. Buspirone acts primarily on serotonin receptors, indicating clear neurotransmitter involvement; hence, this statement misrepresents its pharmacological activity and cannot justify low abuse potential.
D: Its marked sedating effect is troublesome. Buspirone is known for minimal sedation rather than marked drowsiness, so sedation does not contribute to its abuse characteristics or explain why misuse rates remain low.
A new drug was tested in an in vitro system. It was found that only one enantiomer of the racemic pair bound substantially to a specific receptor, whereas the other enantiomer showed negligible binding. Which of the following terms best defines this property?
Rationale:
Stereoselectivity best defines the property where only one enantiomer of a racemic pair binds substantially to a specific receptor while the other shows negligible binding.
Stereoselectivity refers to the preference of a receptor or enzyme to interact predominantly with one stereoisomer over others. This selective binding is crucial in pharmacology, as enantiomers often differ in their biological effects due to distinct three-dimensional orientations influencing receptor recognition and interaction.
B: Intrinsic activity describes the ability of a bound ligand to activate a receptor, not the preference for binding of one enantiomer over another.
C: Affinity measures the strength of binding between a ligand and receptor, but does not specify selective binding to one stereoisomer.
D: Potency reflects the concentration of a drug needed for an effect, unrelated to selective enantiomer binding differences.
Drugs administered via intravenous (IV) route:
Rationale:
Drugs administered via intravenous (IV) route begin distribution into the body immediately. IV administration delivers drugs directly into the bloodstream, bypassing absorption barriers and allowing instantaneous systemic circulation. This rapid distribution contrasts with other routes requiring absorption phases. Consequently, the onset of action is swift, making IV delivery suitable for urgent therapeutic effects and precise control of plasma drug concentrations.
A: Need to be lipid soluble in order to be easily absorbed does not apply because IV drugs bypass absorption barriers, so lipid solubility is irrelevant for immediate bloodstream entry and distribution.
C: Are easily absorbed if they are nonionized is inaccurate since IV administration circumvents traditional absorption processes where ionization status influences membrane permeability.
D: May use pinocytosis to be absorbed is unsuitable as pinocytosis pertains to cellular uptake, not relevant for IV drugs which enter directly into circulation, eliminating absorption mechanisms.
Cross MATCH each drug to the most suitable indication: Constipation with hard stool.
Rationale:
Constipation with hard stool is best treated with Docusate/glycerin. Docusate and glycerin act as stool softeners and lubricants, facilitating easier passage of hard stools by increasing water content and lubricating the bowel. This makes them particularly effective for constipation characterized by dry, compacted feces, providing gentle relief without causing excessive bowel stimulation or cramping.
A: Loperamide primarily slows intestinal motility to reduce diarrhea, making it unsuitable for constipation treatment, especially for hard stools needing softening rather than reduced bowel movement.
B: Paraffin oil acts as a lubricant laxative but is less effective than Docusate/glycerin for hard stools and may cause aspiration risk or interfere with nutrient absorption.
C: Bran/milk of magnesia are bulk-forming and osmotic laxatives respectively, promoting bowel movements by increasing stool bulk or water content, but less specifically soften hard stool compared to Docusate/glycerin.
Monomer units of proteins are known as
Rationale:
Monomer units of proteins are known as amino acids. Amino acids serve as the fundamental building blocks that link together through peptide bonds, forming polypeptides and ultimately functional proteins. Their unique side chains determine protein structure and function, making them essential in biological processes like enzyme activity, cellular signaling, and structural support within organisms.
A: Monosaccharides Primarily constitute carbohydrates, not proteins; they are simple sugars that serve as energy sources rather than structural units in protein synthesis.
B: Prosthetic groups Non-protein components aiding protein function but do not form the protein’s primary structure or monomer units.
D: Purines Nitrogenous bases found in nucleic acids, unrelated to protein monomers, involved in genetic information storage and transfer.
Lanzoprazole is enterically coated because
Rationale:
Lanzoprazole is enterically coated because it is a weak base destroyed by gastric acidity and is ionized in the acidic stomach environment, preventing its effective absorption.
Option D is correct as it combines both crucial reasons: lansoprazole’s chemical instability in acidic pH and its ionization state in the stomach, which necessitate protection from gastric acid through enteric coating for proper delivery and absorption in the intestine.
A: It is a weak base destroyed by gastric acidity but does not address its ionization, which also impedes absorption, making this option incomplete.
B: It is ionized in acid medium of stomach thus not readily absorbed but ignores its chemical degradation in gastric acid, an essential factor for enteric coating.
C: To slow its absorption implies a controlled release purpose, which conflicts with the actual goal of protecting lansoprazole from acid degradation, thus misleading.
Cross Match: Bupropion.
Rationale:
Bupropion is an inhibitor of dopamine and norepinephrine reuptake. This means it increases the levels of these neurotransmitters in the brain by blocking their reabsorption into neurons, which helps alleviate depressive symptoms and supports smoking cessation, distinguishing it from medications targeting serotonin pathways primarily.
A: Norepinephrine serotonin reuptake inhibitor focuses on both norepinephrine and serotonin, but bupropion specifically targets dopamine and norepinephrine, not serotonin, making this description inaccurate for its mechanism.
C: Agonist/Partial 5HT1A agonist involves serotonin receptor activation, which does not align with bupropion’s primary action on dopamine and norepinephrine reuptake inhibition.
D: Selective serotonin reuptake inhibitor exclusively affects serotonin reabsorption, whereas bupropion does not primarily influence serotonin pathways, rendering this choice unsuitable.